297 related articles for article (PubMed ID: 34771575)
1. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
Ayuso-Íñigo B; Méndez-García L; Pericacho M; Muñoz-Félix JM
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771575
[TBL] [Abstract][Full Text] [Related]
2. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
3. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
4. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.
Hu-Lowe DD; Chen E; Zhang L; Watson KD; Mancuso P; Lappin P; Wickman G; Chen JH; Wang J; Jiang X; Amundson K; Simon R; Erbersdobler A; Bergqvist S; Feng Z; Swanson TA; Simmons BH; Lippincott J; Casperson GF; Levin WJ; Stampino CG; Shalinsky DR; Ferrara KW; Fiedler W; Bertolini F
Cancer Res; 2011 Feb; 71(4):1362-73. PubMed ID: 21212415
[TBL] [Abstract][Full Text] [Related]
5. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
6. MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1.
Lin X; Qiu W; Xiao Y; Ma J; Xu F; Zhang K; Gao Y; Chen Q; Li Y; Li H; Qian A
Front Genet; 2019; 10():1397. PubMed ID: 32082362
[TBL] [Abstract][Full Text] [Related]
7. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
8. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
[TBL] [Abstract][Full Text] [Related]
9. Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy.
Hawinkels LJ; Garcia de Vinuesa A; Ten Dijke P
Expert Opin Investig Drugs; 2013 Nov; 22(11):1371-83. PubMed ID: 24053899
[TBL] [Abstract][Full Text] [Related]
10. BMP9 signaling promotes the normalization of tumor blood vessels.
Viallard C; Audiger C; Popovic N; Akla N; Lanthier K; Legault-Navarrete I; Melichar H; Costantino S; Lesage S; Larrivée B
Oncogene; 2020 Apr; 39(14):2996-3014. PubMed ID: 32042114
[TBL] [Abstract][Full Text] [Related]
11. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
Tillet E; Bailly S
Front Genet; 2014; 5():456. PubMed ID: 25620979
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function.
de Vinuesa AG; Bocci M; Pietras K; Ten Dijke P
Biochem Soc Trans; 2016 Aug; 44(4):1142-9. PubMed ID: 27528762
[TBL] [Abstract][Full Text] [Related]
14. Exogenous BMP9 promotes lung fibroblast HFL-1 cell activation via ALK1/Smad1/5 signaling
Wang Y; Sima X; Ying Y; Huang Y
Exp Ther Med; 2021 Jul; 22(1):728. PubMed ID: 34007337
[TBL] [Abstract][Full Text] [Related]
15. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
16. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
[TBL] [Abstract][Full Text] [Related]
17. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
18. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
19. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors.
Ma J; Ren J; Thorikay M; van Dinther M; Sanchez-Duffhues G; Caradec J; Benderitter P; Hoflack J; Ten Dijke P
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
